Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40L

US Patent 8895010 · Granted Nov 25, 2014

Estimated economic value: $463,686,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EPCAM binding fibronectin type III domains2025
Anti-CD137 antibodies and methods of use thereof2025
Polynucleotide encoding anti-TIGIT and anti-CD96 antibodies2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
FN3 domain-siRNA conjugates and uses thereof2025
Anti P2X7 receptor antibodies and fragments thereof2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
CD71 binding fibronectin type III domains2024
Compositions monovalent for CD28 binding and methods of use2024
Compositions monovalent for CD28 binding and methods of use2024
Compositions monovalent for CD28 binding and methods of use2024